Results 121 to 130 of about 5,512,194 (292)

Barriers and Facilitators to the Implementation of the Weekend‐70 Cervical Cancer Screening Programme in Mali: A Multiple Case Study

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Introduction Cervical cancer (CC) represents a significant public health issue in low‐ and middle‐income countries. In Mali, the Weekend‐70 cervical cancer screening programme, initially implemented in Bamako (the capital), is gradually being rolled out in other regions.
Aminata Adama Ndour, Sabina Abou Malham, David‐Martin Milot, Geneviève Baron, Ibrahima Téguété, Mahamane Maiga, Kadidia Bokar   +6 more
wiley   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia, Anne‐Sophie van der Werf‐'t Lam, Madalina Cabuta, Maartje Nielsen, Noah C. Helderman   +4 more
wiley   +1 more source

Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development

International Journal of Cancer, EarlyView.
ABSTRACT Anal high‐grade squamous intraepithelial lesions (HSIL:AIN2/3) are precursors to anal cancer, and early detection and treatment through screening is crucial for effective cancer prevention. Current guidelines recommend anal swab‐based screening and highlight the need for objective biomarkers to improve risk stratification.
Kirsten Rozemeijer, Jürgen Claesen, Fernando Dias Gonçalves Lima, Albertus T. Hesselink, Phoebe Klingers, Timo ter Braak, Yara van den Burgt, Chris J. L. M. Meijer, Jan M. Prins, Henry J. C. de Vries, Mark A. van de Wiel, Renske D. M. Steenbergen   +11 more
wiley   +1 more source

Cases with difficult histological/cytological diagnoses.

, 2013
Cases with difficult histological/cytological diagnoses.
Lorenz Stark (301523), Doris Henne-Bruns (189856), Peter Möller (152217), Andreas Hillenbrand (87264), Thomas F. E. Barth (144301), Petra Kern (301527), Klaus Buttenschoen (301525), Peter Kern (301533), Markus Juchems (301526), Tobias S. Herrmann (301522), Robert L. Rausch (301531), Dennis Tappe (267002), Hanns M. Seitz (301529), Peter Deplazes (102057), Beate Grüner (301524)   +14 more
core   +1 more source

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

International Journal of Cancer, EarlyView.
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold, Ida Laake, Berit Feiring, Kristiane Søreng, Gro Kummeneje Presthus, Glenny Cecilie Alfsen, Irene Kraus Christiansen, Mona Hansen, Hanne Kristiansen, Eirik Olsen, Torstein Gjølgali Frengen, Emily A. Burger, Christine Genieve Monceyron Jonassen, Lill Trogstad   +13 more
wiley   +1 more source

Improved Prediction of Colon Cancer Recurrence Using the ColoNode mRNA Test: A 5‐Year Survival Analysis

International Journal of Cancer, EarlyView.
ABSTRACT Twenty‐five percent of colon cancer patients having curative surgery will recur. Most of them will die from distant metastasis partly due to shortcomings of routine histopathological analysis, that is, undetected tumor cells in the regional lymph node field.
Basel Sitohy, Gudrun Lindmark, Anne Israelsson, Lina Olsson, Tamer Roshdy, Joel Blomqvist, Sara Kero, Mattias Söderholm, Annamaria Turi, Thorbjörn Sakari, Michiel Dooper, George Dafnis, Pehr Forsberg, Susanne Skovsted, Maria Walldén, Chih‐Han Kung, Martin Rutegård, Johanna Nordmyr, Måns Muhrbeck, Sten Hammarström, Marie‐Louise Hammarström   +20 more
wiley   +1 more source

Histopathological and cytological diagnoses in considered groups.

, 2019
Histopathological and cytological diagnoses in considered groups.
Przemysław Dyrla (6645809), Stanisław Niemczyk (6645821), Daniel Schneditz (504840), Arkadiusz Lubas (6645824), Jerzy Gil (6645812), Krzysztof Kosik (6645815), Marek Saracyn (6645818)   +6 more
core   +1 more source

Invasive Cervical Cancers After an HPV‐Negative Test: Insights From HPV Testing Histories

International Journal of Cancer, EarlyView.
ABSTRACT Human papillomavirus (HPV) testing is the primary method for cervical screening, and a negative HPV test is associated with a very low subsequent risk of invasive cancer. Nevertheless, some cervical cancers are diagnosed following an HPV‐negative test.
Sadaf Sakina Hassan, Sara Nordqvist Kleppe, Nijin Asinger, Jiangrong Wang, Joakim Dillner, Laila Sara Arroyo Mühr   +5 more
wiley   +1 more source

Cytological diagnostic categories of both needles.

, 2016
Cytological diagnostic categories of both needles.
Seung Woo Park (193961), Seungmin Bang (799806), Se Woo Park (2697628), Si Young Song (193955), Moon Jae Chung (799802), Jeong Yup Park (2697631), Sang Hoon Lee (211083), Jae Bock Chung (2697634), Hee Seung Lee (2697640), Hoguen Kim (173828), Hyun Jik Lee (2697637)   +10 more
core   +1 more source

Validation of the WID‐CIN Methylation Test for Detection of Cervical Intraepithelial Neoplasia Grade 3 or Worse in an Independent Cohort

International Journal of Cancer, EarlyView.
ABSTRACT Many cervical screening programmes rely on cytology for triage of high‐risk human papillomavirus (hrHPV) positive women. However, cytological triage has variable and often limited sensitivity, and its availability can be restricted in resource‐poor settings.
Laura Burney Ellis, Sarah J. Bowden, Jack Tighe, Muhammad Habiburrahman, Katerina‐Vanessa Savva, Maria Paraskevaidi, Maria Nasioutziki, Chris J. Peters, James M. Flanagan, Maria Kyrgiou   +9 more
wiley   +1 more source